Review





Similar Products

annexin v fitc apoptosis detection kit  (Vazyme Biotech Co)
99
Vazyme Biotech Co annexin v fitc apoptosis detection kit
Exosomes derived from low-passage DPCs regulated HFSC proliferation. (A) Indirect immunofluorescence showing ALPL and PCNA expression in low-passage (P1) and high-passage (P8) DPCs (scale bar = 50 μm). (B) RT-qPCR analysis of HF development-related gene expression in P1 and P8 DPCs (unpaired two-tailed t -test, n = 3). (C) TEM images of exosomes from P1 DPCs (DPC-Exos P1) and P8 DPCs (DPC-Exos P8). (D) NTA measurement of particle size of DPC-Exos P1 and DPC-Exos P8. (E) Western blot detection of exosome-specific proteins in DPC-Exos P1 and DPC-Exos P8. (F) CCK-8 assay evaluating HFSC proliferation after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 5). (G) Flow cytometry analysis of HFSC <t>apoptosis</t> after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 3). ∗ P < 0.05, ∗∗ P < 0.01.
Annexin V Fitc Apoptosis Detection Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annexin v fitc apoptosis detection kit/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
annexin v fitc apoptosis detection kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
tunel apoptosis detection kit  (MedChemExpress)
94
MedChemExpress tunel apoptosis detection kit
Exosomes derived from low-passage DPCs regulated HFSC proliferation. (A) Indirect immunofluorescence showing ALPL and PCNA expression in low-passage (P1) and high-passage (P8) DPCs (scale bar = 50 μm). (B) RT-qPCR analysis of HF development-related gene expression in P1 and P8 DPCs (unpaired two-tailed t -test, n = 3). (C) TEM images of exosomes from P1 DPCs (DPC-Exos P1) and P8 DPCs (DPC-Exos P8). (D) NTA measurement of particle size of DPC-Exos P1 and DPC-Exos P8. (E) Western blot detection of exosome-specific proteins in DPC-Exos P1 and DPC-Exos P8. (F) CCK-8 assay evaluating HFSC proliferation after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 5). (G) Flow cytometry analysis of HFSC <t>apoptosis</t> after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 3). ∗ P < 0.05, ∗∗ P < 0.01.
Tunel Apoptosis Detection Kit, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tunel apoptosis detection kit/product/MedChemExpress
Average 94 stars, based on 1 article reviews
tunel apoptosis detection kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
annexin v pe  (Vazyme Biotech Co)
97
Vazyme Biotech Co annexin v pe
Exosomes derived from low-passage DPCs regulated HFSC proliferation. (A) Indirect immunofluorescence showing ALPL and PCNA expression in low-passage (P1) and high-passage (P8) DPCs (scale bar = 50 μm). (B) RT-qPCR analysis of HF development-related gene expression in P1 and P8 DPCs (unpaired two-tailed t -test, n = 3). (C) TEM images of exosomes from P1 DPCs (DPC-Exos P1) and P8 DPCs (DPC-Exos P8). (D) NTA measurement of particle size of DPC-Exos P1 and DPC-Exos P8. (E) Western blot detection of exosome-specific proteins in DPC-Exos P1 and DPC-Exos P8. (F) CCK-8 assay evaluating HFSC proliferation after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 5). (G) Flow cytometry analysis of HFSC <t>apoptosis</t> after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 3). ∗ P < 0.05, ∗∗ P < 0.01.
Annexin V Pe, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annexin v pe/product/Vazyme Biotech Co
Average 97 stars, based on 1 article reviews
annexin v pe - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
tunel brightgreen apoptosis detection kit  (Vazyme Biotech Co)
99
Vazyme Biotech Co tunel brightgreen apoptosis detection kit
Safety evaluation of orally administered nanofibrils. (a – b) Biodistribution analysis: (a) In vivo fluorescence imaging and (b) ex vivo organ distribution of Cy5.5-labeled nanofibrils and monomers (n = 3). (c) mRNA levels of inflammatory markers in the colon (n = 6). (d) Histopathological evaluation of intestinal tissues by H&E staining (n = 3). (e – f) <t>Apoptosis</t> assessment: (e) Representative <t>TUNEL</t> staining images and (f) quantitative analysis revealing comparable apoptotic cell counts across groups (n = 3). (g – k) Gut microbiota profiling following 21-day oral administration (n = 6): (g) Relative abundance of microbial taxa at genus level; (h) Alpha diversity analysis; (i) Beta diversity analysis; (j) LEfSe analysis; (k) KEGG pathway enrichment analysis.
Tunel Brightgreen Apoptosis Detection Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tunel brightgreen apoptosis detection kit/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
tunel brightgreen apoptosis detection kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
annexin v fitc pi apoptosis kit  (Vazyme Biotech Co)
99
Vazyme Biotech Co annexin v fitc pi apoptosis kit
Safety evaluation of orally administered nanofibrils. (a – b) Biodistribution analysis: (a) In vivo fluorescence imaging and (b) ex vivo organ distribution of Cy5.5-labeled nanofibrils and monomers (n = 3). (c) mRNA levels of inflammatory markers in the colon (n = 6). (d) Histopathological evaluation of intestinal tissues by H&E staining (n = 3). (e – f) <t>Apoptosis</t> assessment: (e) Representative <t>TUNEL</t> staining images and (f) quantitative analysis revealing comparable apoptotic cell counts across groups (n = 3). (g – k) Gut microbiota profiling following 21-day oral administration (n = 6): (g) Relative abundance of microbial taxa at genus level; (h) Alpha diversity analysis; (i) Beta diversity analysis; (j) LEfSe analysis; (k) KEGG pathway enrichment analysis.
Annexin V Fitc Pi Apoptosis Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annexin v fitc pi apoptosis kit/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
annexin v fitc pi apoptosis kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
annexin v fitc pi  (Vazyme Biotech Co)
99
Vazyme Biotech Co annexin v fitc pi
Safety evaluation of orally administered nanofibrils. (a – b) Biodistribution analysis: (a) In vivo fluorescence imaging and (b) ex vivo organ distribution of Cy5.5-labeled nanofibrils and monomers (n = 3). (c) mRNA levels of inflammatory markers in the colon (n = 6). (d) Histopathological evaluation of intestinal tissues by H&E staining (n = 3). (e – f) <t>Apoptosis</t> assessment: (e) Representative <t>TUNEL</t> staining images and (f) quantitative analysis revealing comparable apoptotic cell counts across groups (n = 3). (g – k) Gut microbiota profiling following 21-day oral administration (n = 6): (g) Relative abundance of microbial taxa at genus level; (h) Alpha diversity analysis; (i) Beta diversity analysis; (j) LEfSe analysis; (k) KEGG pathway enrichment analysis.
Annexin V Fitc Pi, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annexin v fitc pi/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
annexin v fitc pi - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
annexin v fitc pi apoptosis detection kit  (Vazyme Biotech Co)
99
Vazyme Biotech Co annexin v fitc pi apoptosis detection kit
Safety evaluation of orally administered nanofibrils. (a – b) Biodistribution analysis: (a) In vivo fluorescence imaging and (b) ex vivo organ distribution of Cy5.5-labeled nanofibrils and monomers (n = 3). (c) mRNA levels of inflammatory markers in the colon (n = 6). (d) Histopathological evaluation of intestinal tissues by H&E staining (n = 3). (e – f) <t>Apoptosis</t> assessment: (e) Representative <t>TUNEL</t> staining images and (f) quantitative analysis revealing comparable apoptotic cell counts across groups (n = 3). (g – k) Gut microbiota profiling following 21-day oral administration (n = 6): (g) Relative abundance of microbial taxa at genus level; (h) Alpha diversity analysis; (i) Beta diversity analysis; (j) LEfSe analysis; (k) KEGG pathway enrichment analysis.
Annexin V Fitc Pi Apoptosis Detection Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annexin v fitc pi apoptosis detection kit/product/Vazyme Biotech Co
Average 99 stars, based on 1 article reviews
annexin v fitc pi apoptosis detection kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


Exosomes derived from low-passage DPCs regulated HFSC proliferation. (A) Indirect immunofluorescence showing ALPL and PCNA expression in low-passage (P1) and high-passage (P8) DPCs (scale bar = 50 μm). (B) RT-qPCR analysis of HF development-related gene expression in P1 and P8 DPCs (unpaired two-tailed t -test, n = 3). (C) TEM images of exosomes from P1 DPCs (DPC-Exos P1) and P8 DPCs (DPC-Exos P8). (D) NTA measurement of particle size of DPC-Exos P1 and DPC-Exos P8. (E) Western blot detection of exosome-specific proteins in DPC-Exos P1 and DPC-Exos P8. (F) CCK-8 assay evaluating HFSC proliferation after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 5). (G) Flow cytometry analysis of HFSC apoptosis after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 3). ∗ P < 0.05, ∗∗ P < 0.01.

Journal: Non-coding RNA Research

Article Title: Exosomal miRNA-218–5p derived from low-passage dermal papilla cells modulates hair follicle growth and development

doi: 10.1016/j.ncrna.2026.01.004

Figure Lengend Snippet: Exosomes derived from low-passage DPCs regulated HFSC proliferation. (A) Indirect immunofluorescence showing ALPL and PCNA expression in low-passage (P1) and high-passage (P8) DPCs (scale bar = 50 μm). (B) RT-qPCR analysis of HF development-related gene expression in P1 and P8 DPCs (unpaired two-tailed t -test, n = 3). (C) TEM images of exosomes from P1 DPCs (DPC-Exos P1) and P8 DPCs (DPC-Exos P8). (D) NTA measurement of particle size of DPC-Exos P1 and DPC-Exos P8. (E) Western blot detection of exosome-specific proteins in DPC-Exos P1 and DPC-Exos P8. (F) CCK-8 assay evaluating HFSC proliferation after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 5). (G) Flow cytometry analysis of HFSC apoptosis after treatment with DPC-Exos from P1 and P8 (one-way ANOVA, n = 3). ∗ P < 0.05, ∗∗ P < 0.01.

Article Snippet: The Annexin V-FITC Apoptosis Detection Kit (Vazyme, China, Cat No. A214) was employed, and apoptosis rates were analyzed via flow cytometry using a FACSAria SORP instrument (Becton Dickinson, USA).

Techniques: Derivative Assay, Immunofluorescence, Expressing, Quantitative RT-PCR, Gene Expression, Two Tailed Test, Western Blot, CCK-8 Assay, Flow Cytometry

Safety evaluation of orally administered nanofibrils. (a – b) Biodistribution analysis: (a) In vivo fluorescence imaging and (b) ex vivo organ distribution of Cy5.5-labeled nanofibrils and monomers (n = 3). (c) mRNA levels of inflammatory markers in the colon (n = 6). (d) Histopathological evaluation of intestinal tissues by H&E staining (n = 3). (e – f) Apoptosis assessment: (e) Representative TUNEL staining images and (f) quantitative analysis revealing comparable apoptotic cell counts across groups (n = 3). (g – k) Gut microbiota profiling following 21-day oral administration (n = 6): (g) Relative abundance of microbial taxa at genus level; (h) Alpha diversity analysis; (i) Beta diversity analysis; (j) LEfSe analysis; (k) KEGG pathway enrichment analysis.

Journal: Bioactive Materials

Article Title: Food-derived β-lactoglobulin nanofibrils: An efficacy, safe, and scalable solution to overcome oral insulin delivery challenges

doi: 10.1016/j.bioactmat.2025.11.020

Figure Lengend Snippet: Safety evaluation of orally administered nanofibrils. (a – b) Biodistribution analysis: (a) In vivo fluorescence imaging and (b) ex vivo organ distribution of Cy5.5-labeled nanofibrils and monomers (n = 3). (c) mRNA levels of inflammatory markers in the colon (n = 6). (d) Histopathological evaluation of intestinal tissues by H&E staining (n = 3). (e – f) Apoptosis assessment: (e) Representative TUNEL staining images and (f) quantitative analysis revealing comparable apoptotic cell counts across groups (n = 3). (g – k) Gut microbiota profiling following 21-day oral administration (n = 6): (g) Relative abundance of microbial taxa at genus level; (h) Alpha diversity analysis; (i) Beta diversity analysis; (j) LEfSe analysis; (k) KEGG pathway enrichment analysis.

Article Snippet: Tissue sections were fixed in paraformaldehyde, and apoptosis detection was performed using the TUNEL BrightGreen Apoptosis Detection Kit (Vazyme, A112-03) following the manufacturer's instructions.

Techniques: In Vivo, Fluorescence, Imaging, Ex Vivo, Labeling, Staining, TUNEL Assay